Filing Flows › Comparisons › BFRI vs ABEO
Biofrontera vs Abeona Therapeutics: BFRI and ABEO compared
Biofrontera is the larger company: $12.0M of revenue in its latest quarter (Q2 2026) against $11.4M for Abeona Therapeutics (Q2 2026). Abeona Therapeutics is growing faster (28× against +33% a year earlier). Biofrontera is more profitable, with an operating margin of -4.4% against -120.0%.
Where the money goes: BFRI and ABEO
Biofrontera (BFRI) · Q2 2026
Biofrontera, Q2 2026: revenue $12.0M (+33% year over year), operating margin -4.4%, net loss $604K, operating cash flow −$1.7M. The chart follows the revenue to costs, profit and cash.
Abeona Therapeutics (ABEO) · Q2 2026
Abeona Therapeutics, Q2 2026: revenue $11.4M (28× year over year), operating margin -120.0%, net loss $20.2M, operating cash flow −$17.5M. The chart follows the revenue to costs, profit and cash.
| Biofrontera (BFRI) | Abeona Therapeutics (ABEO) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $12.0M | $11.4M |
| Revenue growth, Y/Y | +33% | 28× |
| Operating margin | -4.4% | -120.0% |
| Net earnings | −$604K | −$20.2M |
| Net margin | -5.0% | -177.4% |
| Operating cash flow | −$1.7M | −$17.5M |
Questions
Which is bigger, Biofrontera or Abeona Therapeutics?
Biofrontera is the larger company: $12.0M of revenue in its latest quarter (Q2 2026) against $11.4M for Abeona Therapeutics (Q2 2026).
Is Biofrontera or Abeona Therapeutics growing faster?
Abeona Therapeutics is growing faster (28× against +33% a year earlier).
Which is more profitable, Biofrontera or Abeona Therapeutics?
Biofrontera is more profitable, with an operating margin of -4.4% against -120.0%.
More: Biofrontera earnings · how Biofrontera makes money · Abeona Therapeutics earnings · how Abeona Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.